Healthcare provider profile · identity verified

Deepti Smitha Kurra, MD

Family Practice · MARION, IA · NPI 1255561023

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	753	197
Levothyroxine Sodium	Levothyroxine Sodium	675	152
Lisinopril	Lisinopril	428	117
Omeprazole	Omeprazole	329	89
Rosuvastatin Calcium	Rosuvastatin Calcium	264	62
Amlodipine Besylate	Amlodipine Besylate	263	70
Gabapentin	Gabapentin	252	81
Losartan Potassium	Losartan Potassium	246	65
Hydrochlorothiazide	Hydrochlorothiazide	197	57
Metformin Hcl Er	Metformin Hcl	184	50
Metoprolol Succinate	Metoprolol Succinate	182	49
Pantoprazole Sodium	Pantoprazole Sodium	182	52
Alendronate Sodium	Alendronate Sodium	171	47
Sertraline Hcl	Sertraline Hcl	158	40
Pravastatin Sodium	Pravastatin Sodium	147	35
Metformin Hcl	Metformin Hcl	142	33
Simvastatin	Simvastatin	137	34
Meloxicam	Meloxicam	136	57
Montelukast Sodium	Montelukast Sodium	127	29
Buspirone Hcl	Buspirone Hcl	126	36
Potassium Chloride	Potassium Chloride	119	40
Trazodone Hcl	Trazodone Hcl	116	34
Atenolol	Atenolol	108	28
Ozempic	Semaglutide	106	25
Albuterol Sulfate Hfa	Albuterol Sulfate	96	44
Duloxetine Hcl	Duloxetine Hcl	95	21
Furosemide	Furosemide	92	34
Famotidine	Famotidine	91	27
Mirtazapine	Mirtazapine	90	19
Allopurinol	Allopurinol	88	25
Fluticasone Propionate	Fluticasone Propionate	87	38
Glipizide Er	Glipizide	84	23
Triamcinolone Acetonide	Triamcinolone Acetonide	81	39
Donepezil Hcl	Donepezil Hcl	80	14
Escitalopram Oxalate	Escitalopram Oxalate	80	19
Metoprolol Tartrate	Metoprolol Tartrate	74	18
Jardiance	Empagliflozin	72	17
Lovastatin	Lovastatin	72	14
Citalopram Hbr	Citalopram Hydrobromide	64	18
Topiramate	Topiramate	60	18
Pregabalin	Pregabalin	59	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	18
Xarelto	Rivaroxaban	55	suppressed
Mupirocin	Mupirocin	50	26
Eliquis	Apixaban	49	11
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	11
Spironolactone	Spironolactone	45	14
Bupropion Xl	Bupropion Hcl	42	14
Januvia	Sitagliptin Phosphate	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	13
Bupropion Hcl Sr	Bupropion Hcl	40	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	18
Tamsulosin Hcl	Tamsulosin Hcl	39	11
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Glipizide	Glipizide	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Nystatin	Nystatin	33	19
Benazepril Hcl	Benazepril Hcl	31	suppressed
Propranolol Hcl Er	Propranolol Hcl	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Arnuity Ellipta	Fluticasone Furoate	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Irbesartan	Irbesartan	27	suppressed
Torsemide	Torsemide	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Cephalexin	Cephalexin	20	11
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Mounjaro	Tirzepatide	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Estradiol	Estradiol	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Ramipril	Ramipril	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Azathioprine	Azathioprine	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Metolazone	Metolazone	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error